Skip to main content

Decibel Therapeutics, Inc.

DBTXDelisted Sep 25, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001656536

Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Decibel Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of DBTX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4240−2
Shares17.9M17.9M+72.5K (+0.4%)
Value$75.2M$62.1M−$13.1M (−17.5%)

New holders (4)

Institutions that held Decibel Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to DBTX in Q3 2022
InstitutionSharesValue% of portfolio
Dimensional Fund Advisors LP41,341$143.0K0.00%
Charles Schwab Investment Management Inc10,345$36.0K0.00%
China Universal Asset Management Co., Ltd.233$1.00K0.00%
Royal Bank of Canada85$00.00%

Sold out (6)

Institutions that held Decibel Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of DBTX in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Two Sigma Securities, LLC17,683$74.0K
Spire Wealth Management16,600$70.0K
MYDA Advisors LLC15,000$63.0K
CSS LLC10,800$45.0K
UBS Group AG1,504$6.00K
Acadian Asset Management LLC1,240$5.00K